Le Lézard
Classified in: Health, Science and technology, Business
Subject: SVY

Boosting Digital Marketing Impact on Pharmaceutical Product Launches through Effective Hiring of Digital Marketing Talent



CHAPEL HILL, N.C., Feb. 23, 2018 /PRNewswire/ -- As digital marketing strategies and tactics evolve in the pharmaceutical industry, companies are fine-tuning how they hire and develop new digital marketing talent.

A Best Practices, LLC study on digital marketing impact found, however, that hiring strategies differ based on company size.

Larger companies covet "interpersonal" and "analytical" skills most in new digital hires, traits which are critical for successfully navigating organizational size and complexity.  For smaller companies, ideal digital marketers must not only serve as ambassadors (interpersonally) and marketers (analytically), but as entrepreneurs be able to draw on healthcare and tech experience to build workable engagement frameworks and make new tools and systems operational, according to the study.

The topic of hiring digital marketing talent is one of many issues addressed in the study, which provides a snapshot of current approaches to improving the impact of digital marketing. The benchmarking research project engaged 31 digital marketing leaders at 24 companies.

The study examines how savvy biopharma digital marketers are enhancing the medical and commercial potential of new products, improving alignment with brand teams, and acquiring and training new digital marketers. The wide-ranging research also examines how digital marketing groups are structured and aligned internally, what services or activities they are most involved with and how they manage and utilize vendors.

"Growing Biopharma Digital Marketing Impact: Digitizing Launch, Developing Talent and Optimizing Service Alignment" is a report that examines a host of key digital marketing operational benchmarks required to achieve best-in-class performance and to foster a stronger digital culture throughout the organization. This 55-page study will serve as a resource for driving digital marketing performance excellence in the healthcare industry.

Topics addressed in the study include:

Download a complimentary report summary at: http://www.best-in-class.com/rr1486.htm.

ABOUT BEST PRACTICES, LLC

Best Practices, LLC is a leading benchmarking, consulting and advisory services firm serving biopharmaceutical and medical device companies worldwide. Best Practices, LLC's clients include all the top 10 and 48 of the top 50 global healthcare companies. The firm conducts primary research and consulting using its comprehensive proprietary benchmarking tools and analysis. The operational insights, findings and analysis form the basis for our Benchmarking Reports, databases and advisory services to support executives in commercial and R&D operations.

 

SOURCE Best Practices, LLC


These press releases may also interest you

at 19:26
St. Jude Children's Research Hospital (St. Jude), the U.S. hospital leading the way...

at 19:00
Download the full report: https://www.reportbuyer.com/product/5503229 The market is still dominated by the incumbent Telmex and Grupo Televisa, which together retain about two thirds of subscribers. A 2013 telecom reform law set up a new regulator...

at 19:00
ModulTrade will provide the platform for the first blockchain auction for charity purposes during the VIP dinner on Mining Conference in Tbilisi, Georgia, on September 22nd. On September 22nd, ModulTrade will be participating in the World Mining...

at 18:46
BlackChain Solutions Inc. (the "Company" or "BlackChain") , FWB: B2IN), an analytics software company, announces that at market open Tuesday, September 25, 2018, the Company's common shares will commence trading on two (2) old for one (1) new share...

at 18:45
DigiCAP (KOSDAQ:197140), a premier provider of proven NextGen broadcast platforms, and ONEMedia have agreed to deploy a significant number of SmartXess home gateways for ONEMedia's NextGen broadcast system in Dallas, Texas. ONEMedia is the...

at 18:44
Nearly 200 academic and industry researchers gathered this week to share updates on preclinical and clinical-stage Alzheimer's disease research at the 19th International Conference on Alzheimer's Drug Discovery. The two-day conference, organized by...




News published on 23 february 2018 at 13:50 and distributed by: